Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial
収録刊行物
-
- Multiple Sclerosis and Related Disorders
-
Multiple Sclerosis and Related Disorders 47 102641-, 2021-01
Elsevier BV